e-learning
resources
Barcelona 2010
Monday, 20.09.2010
The role of biomarkers in lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identification of membrane-associated proteins as new candidate biomarkers of small-cell lung cancer
S. Ocak, S. R. Stuart, J. A. Ausborn, D. B. Friedman, P. P. Massion (Nashville, United States Of America)
Source:
Annual Congress 2010 - The role of biomarkers in lung cancer
Session:
The role of biomarkers in lung cancer
Session type:
Oral Presentation
Number:
1944
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ocak, S. R. Stuart, J. A. Ausborn, D. B. Friedman, P. P. Massion (Nashville, United States Of America). Identification of membrane-associated proteins as new candidate biomarkers of small-cell lung cancer. Eur Respir J 2010; 36: Suppl. 54, 1944
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Amorfous components of the extracellular matrix have impact as new biochemical markers on malignancy characterization and prognosis of non-small cell lung cancer
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011
Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Identification of a novel crizotinib-sensitive BCL11A-ALK gene fusion in a nonsmall cell lung cancer patient
Source: Eur Respir J , 49 (4) 1602149; DOI: 10.1183/13993003.02149-2016
Year: 2017
Identification of tumor-associate proteins in stage-I lung squamous cancer by proteomics
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
Identification of predictive biomarkers of immunotherapy response in non-small cell lung cancer by multiparametric analysis
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021
Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: ERS Lung Science Conference 2017
Year: 2017
Soluble non-invasive markers in non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 459s
Year: 2005
Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Which gene expression signatures in pharmacogenomic strategies for lung cancer?
Source: Annual Congress 2010 - Customised chemotherapy for lung cancer
Year: 2010
Gene expression profiles predict survival of patients with advanced non-small cell lung cancers
Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer
Year: 2010
Prognostic and potential therapeutic impact of prostate specific membrane antigen expression in non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Targeting Tryptophan metabolism pathway as a therapeutic strategy for non-small cell lung cancer
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
Hypoxia-response gene signatures as predictive and prognostic biomarkers in advanced non-squamous non-small cell lung cancer patients
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Distinct BARD1 isoforms expressed in lung cancer potential targets for treatment
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients?
Source: Eur Respir J 2015; 46: 1548-1550
Year: 2015
Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival
Source: Eur Respir J 2011; 37: 617-623
Year: 2011
Gefitinib selectively targets non-small cell lung cancer cells through inhibition of Forkhead box M1
Source: Annual Congress 2011 - Treatment of lung cancer
Year: 2011
Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013
Gene modules in non-small cell lung cancer
Source: Annual Congress 2009 - Basic science and lung cancer
Year: 2009
LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept